P3-04-03: Identification of Hormone-Responsive Genes as Biomarkers for Menstrual Cycle Phases and Menopausal Status.

@article{Wang2011P30403IO,
  title={P3-04-03: Identification of Hormone-Responsive Genes as Biomarkers for Menstrual Cycle Phases and Menopausal Status.},
  author={J. Wang and O. Lee and R. Heinz and D. Ivancic and D. Scholtens and R. Chatterton and Seema A. Khan},
  journal={Cancer Research},
  year={2011},
  volume={71}
}
Background The definition and validation of biomarkers in archived breast tissue samples for prognostic research is limited by the fact that the exact menstrual cycle phases and menopausal status at the time of tissue sampling is often unknown or not accurate by patient survey. Biomarkers that vary with menstrual cycle phases in premenopausal women would be difficult to standardize. There are also significant differences in gene expression in pre- and post-menopausal women. Therefore, menstrual… Expand
Progestin effects on cell proliferation pathways in the postmenopausal mammary gland
TLDR
The findings indicate that estrogen + progestin therapy results in a distinct molecular profile compared to estrogen-alone or tibolone therapy, including upregulation of key growth factor targets associated with mammary carcinogenesis in mouse models. Expand
Comment on “Progesterone/RANKL Is a Major Regulatory Axis in the Human Breast”
In vivo menstrual cycle data support the findings by Tanos et al. that progesterone regulates RANKL in an ex vivo microstructure model of the human breast, but dispute the suppression of estradiol onExpand